TTD | Drug: D0L2JM

Drug General Information
Drug ID	D0L2JM
Former ID	DIB015059
Drug Name	Levomequitazine
Synonyms	V-0114; V-0114CP
Drug Type	Small molecular drug
Indication	Seasonal allergic rhinitis [ICD9: 472.0, 477; ICD10:J00, J30, J31.0]		Phase 3	[549265]
Company	Pierre Fabre SA
Formula	C20H22N2S
Canonical SMILES	N1(c2c(Sc3c1cccc3)cccc2)C[C@H]1[C@H]2CCN(C1)CC2
PubChem Compound ID	6992284
Target and Pathway
Target(s)	Histamine receptor	Target Info	Antagonist	[534548]
References
Ref 549265	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034359)
Ref 534548	Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes. J Pharmacol Exp Ther. 1998 Feb;284(2):437-42.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information